Clinical significance of anti-dense fine speckled 70 antibody in patients with fibromyalgia.
Conclusions: Anti-DFS70 antibodies may represent a useful biomarker for differentiating between FM and other autoimmune diseases. The levels of anti-DFS70 antibodies were also significantly higher among patients with arthralgia and sleep disturbances. Further investigations are necessary to evaluate the relationships between anti-DFS70 antibodies and other cytokines as a predictive marker for pain.
PMID: 29166758 [PubMed - as supplied by publisher]
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Jeong J, Kim DH, Park G, Park S, Kim HS Tags: Korean J Intern Med Source Type: research
More News: Autoimmune Disease | Chronic Pain | Cystitis | Fibromyalgia | Internal Medicine | Laboratory Medicine | Lupus | Pain | Rheumatology | Sleep Disorders | Sleep Medicine